Tricyclic compounds as TXA.sub.2 antagonists

Details Tricyclic compounds as TXA.sub.2 antagonists Tricyclic compounds as TXA.sub.2 antagonists

1990-11-14

1992-06-02

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514394, 514397, 514399, 514400, 514431, 514451, 548327, 548329, 548330, 548333, 548336, 548311, 549 12, 549 16, 549354, A61K 31415, C07D41106

Patent

active

051187019

ABSTRACT:
Novel tricyclic compound represented by formula (I): ##STR1## possess a TXA.sub.2 biosynthesis inhibiting activity and/or a TXA.sub.2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.

REFERENCES:
patent: 3354155 (1967-11-01), Tretler
patent: 3420851 (1969-01-01), Bloom et al.
patent: 4282365 (1981-08-01), Rokach et al.
patent: 4396550 (1983-08-01), Takizawa et al.
patent: 4465835 (1984-08-01), Takizawa et al.
patent: 4585788 (1986-04-01), Helsley et al.
patent: 4596804 (1986-06-01), Takizawa et al.
patent: 4749703 (1988-06-01), Uno et al.
Ueno et al., J. Med. Chem., "6,11-Dihydroxodibenz [b,e]oxepinaceticacids with potent antiinflammatory activity", 19(7), pp. 941-946 (1976).
Tsukada et al., J. Med. Chem., "Nonsteroidal antiinflammatory Agents", 21(7) pp. 633-639 (1978).
Aultz et al., J. Med. Chem., "Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents", 20(11), pp. 1499-1501 (1977).
J. Metusova et al., Arz. Forcsh, "Pharmakologische Eigenshaften der 6,11-Dihydrodibenz (b,e)-Thiepine-Derivate", 13 pp. 1039-1045 (1963).

Affiliated with

Also associated with

Rating

Tricyclic compounds as TXA.sub.2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic compounds as TXA.sub.2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds as TXA.sub.2 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2228743